AR229954A1 - Procedimiento de preparacion de 1,2-bis(nicotinamido)propano o sus sales farmaceuticamente adecuadas - Google Patents

Procedimiento de preparacion de 1,2-bis(nicotinamido)propano o sus sales farmaceuticamente adecuadas

Info

Publication number
AR229954A1
AR229954A1 AR283298A AR28329880A AR229954A1 AR 229954 A1 AR229954 A1 AR 229954A1 AR 283298 A AR283298 A AR 283298A AR 28329880 A AR28329880 A AR 28329880A AR 229954 A1 AR229954 A1 AR 229954A1
Authority
AR
Argentina
Prior art keywords
nicotinamide
propane
bis
procedure
preparation
Prior art date
Application number
AR283298A
Other languages
English (en)
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Application granted granted Critical
Publication of AR229954A1 publication Critical patent/AR229954A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
AR283298A 1979-11-22 1980-11-19 Procedimiento de preparacion de 1,2-bis(nicotinamido)propano o sus sales farmaceuticamente adecuadas AR229954A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP15067479A JPS5675474A (en) 1979-11-22 1979-11-22 Nicotinamide derivative and medicine containing the same

Publications (1)

Publication Number Publication Date
AR229954A1 true AR229954A1 (es) 1984-01-31

Family

ID=15501986

Family Applications (1)

Application Number Title Priority Date Filing Date
AR283298A AR229954A1 (es) 1979-11-22 1980-11-19 Procedimiento de preparacion de 1,2-bis(nicotinamido)propano o sus sales farmaceuticamente adecuadas

Country Status (13)

Country Link
US (1) US4366161A (es)
EP (1) EP0029602B1 (es)
JP (1) JPS5675474A (es)
AR (1) AR229954A1 (es)
AU (1) AU540216B2 (es)
CA (1) CA1147732A (es)
CS (1) CS241475B2 (es)
DE (1) DE3066874D1 (es)
DK (1) DK149807C (es)
ES (1) ES8203349A1 (es)
HU (1) HU180617B (es)
SU (1) SU1053749A3 (es)
ZA (1) ZA807283B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1170214B (it) * 1983-09-12 1987-06-03 Crinos Industria Farmaco Composizione farmaceutica per la cura delle arteriopatie periferiche
FR2556722B1 (fr) * 1983-12-15 1986-09-26 Merck Clevenot Laboratoires N-valproyl-nicotinamide, procede de preparation et utilisation en therapeutique
ATE110058T1 (de) * 1988-12-27 1994-09-15 Chugai Pharmaceutical Co Ltd Reinigungsverfahren für 1,2- bis(nicotinamido)propan.
EP0697169B1 (en) * 1993-05-07 2000-11-15 Chugai Seiyaku Kabushiki Kaisha Organ preservative
JPH09315972A (ja) * 1996-03-22 1997-12-09 Chugai Pharmaceut Co Ltd 脊髄損傷治療剤
US20030032655A1 (en) * 2000-03-17 2003-02-13 Toshio Tanaka Heme oxygenase-1 inducers or induction enhancers
WO2002028392A1 (fr) * 2000-09-29 2002-04-11 Chugai Seiyaku Kabushiki Kaisha Remedes pour des troubles circulatoires cerebraux

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH392507A (de) * 1960-06-27 1965-05-31 Eprova Ag Verfahren zur Herstellung von Nicotinsäure-aminomethylamiden
FR1335517A (fr) * 1962-03-27 1963-08-23 Ciba Geigy Procédé de préparation d'amides hétérocycliques, notamment de la 3, 3-bis-(4-nicotinoylamino-phényl)-butane-2-one
US3697531A (en) * 1971-02-25 1972-10-10 Sterling Drug Inc N,n{40 -alkylenebis(pyridine-carboxamides)
GB1339764A (en) * 1971-03-29 1973-12-05 Ici Ltd Pyridine derivatives

Also Published As

Publication number Publication date
ES497065A0 (es) 1982-04-01
ES8203349A1 (es) 1982-04-01
CA1147732A (en) 1983-06-07
CS241475B2 (en) 1986-03-13
HU180617B (en) 1983-03-28
JPS5675474A (en) 1981-06-22
DK493780A (da) 1981-05-23
SU1053749A3 (ru) 1983-11-07
DK149807B (da) 1986-10-06
AU540216B2 (en) 1984-11-08
DE3066874D1 (en) 1984-04-12
EP0029602A1 (en) 1981-06-03
JPS6155911B2 (es) 1986-11-29
AU6451780A (en) 1981-05-28
ZA807283B (en) 1981-11-25
CS765780A2 (en) 1985-07-16
EP0029602B1 (en) 1984-03-07
US4366161A (en) 1982-12-28
DK149807C (da) 1987-03-23

Similar Documents

Publication Publication Date Title
NO803851L (no) Fremgangsmaate til fremstilling av 4,1`,6`-triklor-4,1`,6`-trideoksy-galaktosukrose
AR224495A1 (es) Procedimiento para la preparacion de derivados de 1-fenil-7,8-dihidroxi o 7,8-dialcanoiloxi-1,3,4,5-tetrahidro-1h-3-benzazepina y sus sales
AR222828A1 (es) Procedimiento para la preparacion de 2,3,4,5-tetrahidro-6-feniltio-1h-3-benzazepinas y sus sales
ES510348A0 (es) "procedimiento de preparacion de nuevos derivados 3,4-dihidro-5h-2,3-benzodiazepinos y de sus sales de adicion acidas farmaceuticamente aceptables".
AR228949A1 (es) Procedimiento para la preparacion de nuevos derivados de pirido(1,2-a)pirimidina y sus sales
DK236377A (da) Fremgangsmade til fremstilling af substituerede pyridiner el6er farmaceutisk acceptable salte deraf
ES508025A0 (es) "procedimiento para preparar derivados de dihidropiridina".
SE7813114L (sv) 3-fluor-10-piperazino-8-substituerade 10,11-di-hydrodibenso(b,f)tiepiner, salter samt forfaranden for framstellning derav
AR228586A1 (es) Procedimiento para preparar derivados de 2,3-dihidrobenzofuran-2-ona o croman-2-ona y sus sales farmaceuticamente aceptables
AR229954A1 (es) Procedimiento de preparacion de 1,2-bis(nicotinamido)propano o sus sales farmaceuticamente adecuadas
IT8023315A0 (it) 2-(3,4,5-trimetossifenil)-tiazoli 4,5-bisostituiti e procedimento per la loro preparazione.
DK75878A (da) Fremgangsmaade til fremstilling af 20,21,-di-noreburnameninderivater eller additionssalte deraf
AR227087A1 (es) Procedimiento para obtener compuestos de s-triazol(4,3-b)-piridazinas y sus sales
AR240924A1 (es) "procedimiento para preparar derivados de 1,3-oxazolidin-2-ona y sus sales".
AR216558A1 (es) Procedimiento de preparacion de 1,3-dihidro-3-(3',4',5'-trimetoxi-estiril)-6-metil-7-hidroxi-furo-(3,4,c)-piridina
DK148302C (da) Analogifremgangsmaade til fremstilling af 1,3-dialkylxanthinderivater
ES513618A0 (es) "procedimiento para la preparacion de derivados de 2-hidroxi-3-azolilpropano".
ES493931A0 (es) Procedimiento de preparacion de nuevos derivados de la 3,4,5-trimetoxi-cinamoil-piperazina
NO158681C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive n2-arylsulfonyl-l-arginamider og farmasoeytisk fordragelige salter derav.
MX143905A (es) Procedimiento para la preparacion de sales de 4-amino bencendiazonio
ES490505A0 (es) Procedimiento de preparacion de nuevos derivados benzo-as- triazinos y de sus sales de adicion acidas, farmaceuticamen-te aceptables
AR216058A1 (es) Procedimiento de preparacion de sulfoximidas sustituidas,y sus sales
ES491608A0 (es) Procedimiento de preparacion de derivados pirazolo (1,5-c) quinazolinos y de sus sales de adicion acidas
ES491732A0 (es) Procedimiento de preparacion de monohidrato de 1,25-dihidro-xi-colecalciferol
ES495745A0 (es) Procedimiento de preparacion de derivados de la piridina.